London, 20 October 2014 – TechNavio, a global tech-focused research firm has announced the publication of its market research report on the Global STD Testing Market 2014-2018, which is expected to grow at a CAGR of 5.64 percent from 2013-2018.
About the Report
The latest report by TechNavio focuses on the growing incidence of STDs in adolescents and young adults as a major driver for growth in STD testing. Young people aged between 15 and 24 account for nearly half of all new STDs and according to a report, 24 percent of chlamydia cases and 34 percent of gonorrhea cases worldwide occur in young people.
The report also highlights ready-to-use-reagents that offer many advantages like avoiding calculation, dilutions, pipetting and time wasting, along with contamination prevention.
“Ready-to-use reagents are in great demand in clinical laboratories and hospitals. An increased focus on infection prevention and on obtaining accurate results in healthcare sector will boost the consumption of these reagents in the coming years,” says Faisal Ghaus, Vice President of TechNavio.
“Easier testing, coupled with heightened awareness of STDs will contribute to strong growth in this market and development of better STD testing technologies over the projected period.”
Key Information Covered in the Report:
Market segmentation, size and forecast through 2018
Market Growth Drivers:
- Growing Incidence of STD in Adolescents and Young Adults
- For a full detailed list, view our report.
Market Challenges:
- Accurate Diagnostic Testing
- For a full detailed list, view our report.
Market Trends:
- Ready-to-Use Reagents
- For a full detailed list, view our report.
Key Vendors:
- Alere Inc.
- Becton, Dickinson and Company (BD)
- bioMérieux SA
- Roche Diagnostics
Other Prominent Vendors:
- Abbott
- Bio-Rad
- Cepheid
- DiaSorin
https://www.technavio.com/%3Cp%3E%3Ca%20href%3D%22http%3A//www.technavio….
